Cynata Therapeutics - Company & Market Research Reports

Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus, using discoveries made at the University of Wisconsin-Madison (UWM). The Cymerus platform technology is based upon stem cells known as mesenchymoangioblasts (MCAs). MCAs are a precursor of mesenchymal stem (or stromal) cells (MSCs), which are at the forefront of a new generation of treatments being investigated for such devastating diseases as osteoarthritis, Crohn's disease and heart disease.